Potential role of tocilizumab in severe gastrointestinal barrier damage after car t-cell therapy - Université de Lille Accéder directement au contenu
Article Dans Une Revue Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi Année : 2021

Potential role of tocilizumab in severe gastrointestinal barrier damage after car t-cell therapy

Résumé

We report a septicemia and disseminated candidiasis due to delayed gastrointestinal mucosae repair in a patient treated with tocilizumab after anti-CD19 CAR T-cell therapy. Tocilizumab could have inhibited intestinal tissue repair and furthered bacteria translocation leading to the invasion of intestinal mucosa by yeasts as IL-6 is known to be involved in mucosal wound healing.

Mots clés

Fichier principal
Vignette du fichier
S1684118221000499.pdf (2.85 Mo) Télécharger le fichier
Origine Fichiers produits par l'(les) auteur(s)

Dates et versions

hal-03533922 , version 1 (09-05-2023)

Licence

Identifiants

Citer

David Beauvais, Oriane Karleskind, Severine Loridant, Remy Nyga, Marie Lamiaux, et al.. Potential role of tocilizumab in severe gastrointestinal barrier damage after car t-cell therapy. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2021, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 54 (2), pp.327-330. ⟨10.1016/j.jmii.2021.02.006⟩. ⟨hal-03533922⟩
32 Consultations
20 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More